IRadimed Corporation provided earnings guidance for the third quarter of 2022. For the quarter, the company expects to report revenue of $13.1 million to $13.3 million, GAAP diluted earnings per share of $0.21 to $0.24.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
43.02 USD | +1.51% | -2.47% | -9.37% |
May. 02 | Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.37% | 537M | |
+75.57% | 12.55B | |
-23.11% | 7.51B | |
+8.75% | 6.74B | |
+14.95% | 5.48B | |
-14.65% | 4.93B | |
+30.59% | 4.71B | |
-24.40% | 3.83B | |
-22.34% | 2.9B | |
+49.50% | 2.49B |
- Stock Market
- Equities
- IRMD Stock
- News IRADIMED CORPORATION
- Iradimed Corporation Provides Earnings Guidance for the Third Quarter of 2022